Cellosaurus logo
expasy logo

Cellosaurus RPCI-WM1/IR (CVCL_VJ33)

[Text][XML][JSON]
Cell line name RPCI-WM1/IR
Accession CVCL_VJ33
Resource Identification Initiative To cite this cell line use: RPCI-WM1/IR (RRID:CVCL_VJ33)
Comments Selected for resistance to: ChEBI; CHEBI_76612; Ibrutinib (Imbruvica).
Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
Sequence variations
  • Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar=VCV000037055; Zygosity=Heterozygous (from parent cell line).
Disease Waldenstrom macroglobulinemia (NCIt: C80307)
Waldenstrom macroglobulinemia (ORDO: Orphanet_33226)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_M087 (RPCI-WM1)
Sex of cell Female
Age at sampling 48Y
Category Cancer cell line
Publications

PubMed=28548645; DOI=10.1038/bcj.2017.40; PMCID=PMC5518884
Aneel Paulus, Sharoon Akhtar, Hafiz Muhammad Yousaf, Alak Manna, Shumail Marshal Paulus, Yamima Bashir, Thomas R. Caulfield, Maja Kristin Kuranz Blake, Kasyapa S. Chitta, Xue Wang, Yan Asmann ...Show all 15 authors... , Roman Hudec, Wolfdieter Springer, Sikander Ailawadhi, Asher A. Chanan-Khan; Show fewer authors
Waldenstrom macroglobulinemia cells devoid of BTK(C481S) or CXCR4(WHIM-like) mutations acquire resistance to ibrutinib through upregulation of Bcl-2 and AKT resulting in vulnerability towards venetoclax or MK2206 treatment.
Blood Cancer J. 7:e565.1-e565.11(2017)

Cross-references
Cell line databases/resources cancercelllines; CVCL_VJ33
Encyclopedic resources Wikidata; Q98129163
Polymorphism and mutation databases Cosmic; 2645647
Entry history
Entry creation07-Sep-2018
Last entry update14-Aug-2025
Version number12